DE69007486D1 - Verwendung von calciumantagonisten für die behandlung von narben. - Google Patents

Verwendung von calciumantagonisten für die behandlung von narben.

Info

Publication number
DE69007486D1
DE69007486D1 DE90912115T DE69007486T DE69007486D1 DE 69007486 D1 DE69007486 D1 DE 69007486D1 DE 90912115 T DE90912115 T DE 90912115T DE 69007486 T DE69007486 T DE 69007486T DE 69007486 D1 DE69007486 D1 DE 69007486D1
Authority
DE
Germany
Prior art keywords
scars
treatment
calcium antagonists
antagonists
calcium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE90912115T
Other languages
English (en)
Other versions
DE69007486T2 (de
Inventor
Raphael C Lee
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Massachusetts Institute of Technology
Original Assignee
Massachusetts Institute of Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Massachusetts Institute of Technology filed Critical Massachusetts Institute of Technology
Publication of DE69007486D1 publication Critical patent/DE69007486D1/de
Application granted granted Critical
Publication of DE69007486T2 publication Critical patent/DE69007486T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
DE69007486T 1989-07-31 1990-07-31 Verwendung von calciumantagonisten für die behandlung von narben. Expired - Lifetime DE69007486T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38760489A 1989-07-31 1989-07-31
PCT/US1990/004294 WO1991001624A2 (en) 1989-07-31 1990-07-31 Use of calcium antagonists for treating scars

Publications (2)

Publication Number Publication Date
DE69007486D1 true DE69007486D1 (de) 1994-04-21
DE69007486T2 DE69007486T2 (de) 1994-08-11

Family

ID=23530617

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69007486T Expired - Lifetime DE69007486T2 (de) 1989-07-31 1990-07-31 Verwendung von calciumantagonisten für die behandlung von narben.

Country Status (5)

Country Link
EP (1) EP0485470B1 (de)
JP (1) JP3149180B2 (de)
CA (1) CA2059558C (de)
DE (1) DE69007486T2 (de)
WO (1) WO1991001624A2 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5569678A (en) * 1989-07-31 1996-10-29 Massachusetts Institute Of Technology Control of wound scar production
ATE341316T1 (de) * 1992-07-20 2006-10-15 Massachusetts Inst Technology Kontrolle der wundvernarbung mit calmodulin- inhibitoren oder protein-kinase-c-inhibitoren
US5552162A (en) * 1993-02-09 1996-09-03 Arch Development Corporation Method for improvement of scar size and appearance
EP0692975A4 (de) * 1993-04-08 2000-11-29 Univ Queensland Verabreichung eines vaso-aktiven wirkstoffes und eines therapeutischen wirkstoffes
FR2740341B1 (fr) * 1995-10-26 1997-12-19 Oreal Utilisation de sel de lanthanide, d'etain, de zinc, de manganese, d'yttrium, de cobalt, de baryum, de strontium dans une composition pour la peau
US6525100B1 (en) 1998-08-03 2003-02-25 W. Jerry Easterling Composition and method for treating peyronie's disease and related fibrotic tissue disorders
US6031005A (en) * 1998-08-03 2000-02-29 Easterling; W. Jerry Composition and method for treating Peyronie's disease and related connective tissue disorders
US6627663B2 (en) 1998-08-03 2003-09-30 W. Jerry Easterling Noninvasive method for treating hemangiomas through transdermal delivery of calcium channel blocker agents and medicament for use in such method
JP3157784B2 (ja) 1998-08-19 2001-04-16 新潟日本電気株式会社 電子写真感光体およびその製造方法
US7094431B2 (en) * 2000-10-12 2006-08-22 Mickey L. Peshoff Method of healing skin wounds in mammals and a composition therefor
DK1631275T3 (da) * 2003-06-09 2008-08-18 Ascend Therapeutics Inc Behandling og forebyggelse af excessiv ardannelse med 4-hydroxy-tamoxifen
GB201119089D0 (en) * 2011-11-04 2011-12-21 Isis Innovation Treatment of musculoskeletal fibroproliferative disorders

Also Published As

Publication number Publication date
CA2059558C (en) 2002-11-12
CA2059558A1 (en) 1991-02-01
WO1991001624A2 (en) 1991-02-21
EP0485470B1 (de) 1994-03-16
JPH05500045A (ja) 1993-01-14
EP0485470A1 (de) 1992-05-20
DE69007486T2 (de) 1994-08-11
WO1991001624A8 (en) 2005-06-16
JP3149180B2 (ja) 2001-03-26

Similar Documents

Publication Publication Date Title
DE59608738D1 (de) Verwendung von epinastin für die behandlung von schmerzen
DE68907909T2 (de) Präparat zur behandlung von erektionsstörungen.
DE68913667D1 (de) Imidazole für die Behandlung von Atherosclerose.
DE3579151D1 (de) Vorrichtung zur behandlung der oberschenkelknochenbrueche.
ATE235906T1 (de) Substituierte phenylpyrimidine derivate, für die behandlung oder prevention von zns-erkrankungen
DE69008820T2 (de) Verfahren zur Behandlung von Polymerisaten.
DE69019488T2 (de) Behandlung von Geflügel.
DE3578611D1 (de) Instrumente zur behandlung von verformten naegeln bei menschlichen patienten.
DE69018043T2 (de) Behandlung von Geflügel.
DE3882775T2 (de) Zusammensetzung zur Behandlung von parodontaler Krankheit.
DE69003009D1 (de) Verfahren zur Behandlung von Fasermaterialien.
DE69007486D1 (de) Verwendung von calciumantagonisten für die behandlung von narben.
DE3889416T2 (de) Wärmebeständiges Schmiermittel zur Behandlung von Kunstfasern.
DE3789079D1 (de) Zusammensetzung für die Behandlung von Fasern.
ATE221763T1 (de) Die verwendung von glyceryltriacetat zur behandlung von onychomykosen
DE58906239D1 (de) Einrichtung zur Behandlung von Erkrankungen, insbesondere der Sehbahn.
DE3856329D1 (de) Verwendung von Ethisterone zur topischen Behandlung von Akne oder androgenetischer Alopezie
DE3481990D1 (de) Benzothiazol-2-sulfonamid-derivate, zur oertlichen behandlung von erhoehtem augeninnendruck.
DE59005545D1 (de) Verwendung von hydroxymischethern als hilfsmittel für die feststoffentwässerung.
DE69007374D1 (de) Injektionssystem für die Behandlung von Zellen.
DE69101847T2 (de) Zubereitung für die Verhütung oder die Behandlung von Hypertriglyceridämie.
DE3785555D1 (de) Verwendung von guaifenesin zur behandlung urologischer beschwerden.
ATE102828T1 (de) Verwendung von calciumantagonisten fuer die behandlung von narben.
DE68926222D1 (de) Verwendung von 1,2,3,4-Tetrahydroacridinen zur Behandlung von AIDS, sowie Verbindungen
DE68918449T2 (de) Siliziumverbindungen zur behandlung von knochen.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition